GJG Life Science

GJG Life Science

GJG Life Science is a New York-based private equity firm concentrated on life sciences investing. The firm's specific founding year and founding principal are not publicly disclosed, but its operational focus suggests it emerged to capture returns in the biotechnology and healthcare technology verticals. The firm pursues a dual strategy of venture and growth investments, covering companies from early-stage through commercial-stage. Its sector focus spans therapeutics, diagnostics, medical devices, and digital health platforms. GJG Life Science typically leads or co-invests in rounds, and its portfolio is concentrated in North American companies. The firm does not publicly list specific portfolio companies or deal values, making independent verification of its holdings difficult. GJG Life Science's exact assets under management and team size are not publicly reported. The firm has no known additional offices outside New York City. There are no disclosed philanthropic vehicles or operating companies associated with the firm. No recent operational events—such as fund closings, leadership changes, or notable exits—have been reported in the public domain within the last 24 months. The firm's structural differentiator is its exclusive focus on life sciences, a niche that requires deep domain expertise in biology, chemistry, and regulatory pathways. By specializing in this single sector, GJG Life Science aims to source proprietary deals and provide informed capital to companies navigating clinical development and FDA approval. Its governance and succession structure remain opaque, as no information about its leadership or ownership is publicly available.